HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 8,113-8,124 of 27,277
Drug study icon
CompletedNCT01346163

PF-03654746 Added to Schizophrenia Treatment and Thinking Skills

About this title

Add On Treatment for Cognitive Deficits in Schizophrenia

Read the official source — NCT01346163
Official study title

A Phase1B Study: A Placebo Controlled Study of PF-03654746 Given as Add-On Treatment of Cognitive Deficits in Schizophrenia

This study has finished and is no longer accepting participants.

In Philadelphia
SchizophreniaMedication studyAges 18–40
Countries
United States
Sponsor
University of Pennsylvania
Device study icon
CompletedNCT04038788

Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating people with Schizophrenia

Official study title

The Effects of High-Definition High-Frequency Transcranial Random Noise Stimulation Over Bilateral Prefrontal Cortex on Illness Symptoms, Clinical Outcomes, Autonomic Function and Brain Oscillatory Activity in Schizophrenia Patients

This study has finished and is no longer accepting participants.

In Taipei
SchizophreniaDevice studyAges 20–65
Countries
Taiwan
Sponsor
Tri-Service General Hospital (TSGH)
Drug study icon
TerminatedNCT00605995

Add-on Simvastatin in Schizophrenia study

Official study title

Add-on Simvastatin in Schizophrenia Trial

This study ended early.

In Ramat Gan
SchizophreniaMedication studyAges 18–70
Countries
Israel
Sponsor
New York State Psychiatric Institute
Drug study icon
CompletedNCT01548612

Sodium Nitroprusside Added to Usual Care for Schizophrenia

About this title

Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia

Read the official source — NCT01548612
Official study title

Randomised Double Blind Placebo Controlled Study of Sodium Nitroprusside Added to Treatment as Usual in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Ribeirão Preto
SchizophreniaMedication studyAges 18–45
Countries
Brazil
Sponsor
University of Sao Paulo
Biological study icon
CompletedEUCTR 2008-005004-13

Add-on Therapie mit Omega-3 Fettsäuren bei Jugendlichen mit hohem Risiko für Schizophrenie und andere psychotische Störungen: eine Multizentren- Replikationsstudie Omega-3 Fatty Acids for Symptomat...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
SchizophreniaHistorical research record
Countries
Austria
Sponsor
Orygen Research Centre

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.